Company Valuation: Nectar Lifesciences Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2020 2021 2022 2023 2024 2025
Market Cap 1 2,198 4,171 5,393 3,577 6,761 5,147
Change - 89.8% 29.3% -33.68% 89.03% -23.88%
Enterprise Value (EV) 1 9,771 12,945 13,810 10,936 12,914 10,769
Change - 32.49% 6.68% -20.81% 18.08% -16.6%
P/E 6.91x -5.69x 21.5x -14.8x 137x -4.53x
PBR 0.19x 0.39x 0.5x 0.34x 0.63x 0.54x
PEG - 0x -0x 0x -1x 0x
Capitalization / Revenue 0.09x 0.27x 0.32x 0.23x 0.4x 0.31x
EV / Revenue 0.41x 0.84x 0.83x 0.72x 0.77x 0.64x
EV / EBITDA 4.44x 11.7x 8.71x 20.3x 8.41x -41.3x
EV / EBIT 6.13x 25.9x 13.6x -211x 13.9x -12.2x
EV / FCF 7.5x 6.19x -28.1x 42.1x 13.3x -63x
FCF Yield 13.3% 16.2% -3.56% 2.37% 7.52% -1.59%
Dividend per Share 2 0.05 - - - - -
Rate of return 0.51% - - - - -
EPS 2 1.418 -3.27 1.117 -1.08 0.22 -5.07
Distribution rate 3.53% - - - - -
Net sales 1 23,664 15,433 16,689 15,237 16,846 16,704
EBITDA 1 2,201 1,102 1,586 539.5 1,536 -260.8
EBIT 1 1,593 499.9 1,016 -51.73 928.4 -884.7
Net income 1 317.9 -732.6 250.5 -241.8 49.95 -1,137
Net Debt 1 7,573 8,774 8,417 7,359 6,152 5,623
Reference price 2 9.80 18.60 24.05 15.95 30.15 22.95
Nbr of stocks (in thousands) 224,261 224,261 224,261 224,261 224,261 224,261
Announcement Date 8/14/20 A 8/24/21 A 8/24/22 A 8/11/23 A 8/14/24 A 8/26/25 A
1INR in Million2INR
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 20.7M
36.23x6.85x23.66x0.8% 49.64B
18.74x2.13x10.03x1.28% 36.54B
28.05x3.42x17.71x0.88% 12.22B
26.06x3.85x15.68x0.6% 11.48B
19.18x3.35x12.04x3.47% 9.04B
16.01x2.06x6.93x3.24% 6.94B
8.16x1.91x5x5.31% 6.74B
33.16x3.77x16.04x0.24% 6.45B
Average 23.20x 3.42x 13.39x 1.98% 15.45B
Weighted average by Cap. 26.45x 4.21x 16.05x 1.41%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. NECLIFE Stock
  4. Valuation Nectar Lifesciences Limited